Clinic PET Scan Radiation 
Imaging Technology
APRIL 24, 2024
The findings were published in Clinical Nuclear Medicine. The newly published study involved performing PET scans on 22 people with MS and eight healthy controls. Those being treated with low-efficacy treatments had more abnormalities on their PET scans, suggesting more microglial cell activation.
Future Teleradiology
NOVEMBER 30, 2023
Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Embark on a journey into the world of medical imaging as we unravel the distinctions between two powerful diagnostic tools—Computed Tomography (CT) scans and Positron Emission Tomography (PET) scans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
SEPTEMBER 12, 2023
Zelefsky brings an unparalleled level of expertise and leadership that will further elevate our team at Perlmutter Cancer Center,” said Alec Kimmelman, MD, PhD , the Anita Steckler and Joseph Steckler Chair of the Department of Radiation Oncology. This procedure is often combined with other forms of radiation, such as external radiation.
AuntMinnie
OCTOBER 2, 2024
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PET scans predict patient response to Pluvicto.
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Imaging Technology
JUNE 24, 2023
“Up until now, PET has been useful for the study of neurological phenomena and for diagnostic purposes, but its potential has been somewhat limited by the poor spatial resolution of current PET systems,” said Vincent Doyon, a master’s student in Radiation Sciences and Biomedical Imaging at the 8 in Québec, Canada.
AuntMinnie
JUNE 20, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Expert insights. Personalized for you.
102 
Let's personalize your content